Hale B Caglar
Overview
Explore the profile of Hale B Caglar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dagoglu N, Karaman S, Caglar H, Oral E
Cureus
. 2019 May;
11(2):e4103.
PMID: 31057997
Mounting evidence suggests that radiation stimulates the immune system and this contributes to the abscopal effect, which is defined as "response at a distance from the irradiated volume." Though identified...
2.
Allen A, Albert M, Caglar H, Zygmanski P, Soto R, Killoran J, et al.
J Appl Clin Med Phys
. 2011 May;
12(2):3357.
PMID: 21587180
Locally advanced non-small-cell lung cancer (NSCLC) is a common disease with a low overall survival even with aggressive treatments. Standard imaging (CT and PET/CT) provide no information about normal lung...
3.
Abacioglu U, Caglar H, Yumuk P, Akgun Z, Atasoy B, Sengoz M
J Neurooncol
. 2010 Sep;
103(3):585-93.
PMID: 20878446
The current standard therapy for newly diagnosed glioblastoma is multimodal, comprising surgical resection plus radiotherapy and concurrent temozolomide, then adjuvant temozolomide for 6 months. This has been shown to provide...
4.
Caglar H, Othus M, Allen A
Radiother Oncol
. 2010 Sep;
97(1):48-53.
PMID: 20832884
Purpose: To define optimization parameters for limiting esophageal toxicity with concurrent chemoradiation (CRT) for non-small cell lung cancer (NSCLC). Materials And Methods: A retrospective analysis of patients treated with concurrent...
5.
Alexander B, Othus M, Caglar H, Allen A
Int J Radiat Oncol Biol Phys
. 2010 Jul;
79(5):1381-7.
PMID: 20605346
Purpose: To investigate whether primary tumor and nodal volumes defined on radiotherapy planning scans are correlated with outcome (survival and recurrence) after combined-modality treatment. Methods And Materials: A retrospective review...
6.
Basaran G, Devrim C, Caglar H, Gulluoglu B, Kaya H, Seber S, et al.
Med Oncol
. 2010 Apr;
28(3):726-32.
PMID: 20390469
It has been shown that breast cancer patients with N3a (10 positive lymph nodes) had a poor prognosis. We planned to investigate the clinical outcome BC patients who presented with...
7.
Caglar H, Baldini E, Othus M, Rabin M, Bueno R, Sugarbaker D, et al.
Cancer
. 2009 Jun;
115(18):4156-66.
PMID: 19551884
Background: The objective of this study was to identify the factors associated with improved outcome after treatment for stage III nonsmall cell lung cancer (NSCLC). Methods: A retrospective review of...
8.
Akkiprik M, Sonmez O, Gulluoglu B, Caglar H, Kaya H, Demirkalem P, et al.
Pathol Oncol Res
. 2008 Dec;
15(3):359-68.
PMID: 19048399
p53 polymorphic variants play an important role in the determination of tumor phenotype and characteristics in breast cancer. In this study, we examined three common polymorphisms in p53 gene and...
9.
Caglar H, Tishler R, Othus M, Burke E, Li Y, Goguen L, et al.
Int J Radiat Oncol Biol Phys
. 2008 May;
72(4):1110-8.
PMID: 18468812
Purpose: To evaluate early swallowing after intensity-modulated radiotherapy for head and neck squamous cell carcinoma and determine factors correlating with aspiration and/or stricture. Methods And Materials: Consecutive patients treated with...
10.
Caglar H, Allen A
Clin Adv Hematol Oncol
. 2007 Aug;
5(6):425-31.
PMID: 17679916
Intensity-modulated radiation therapy (IMRT) is a new radiation delivery technique that allows more precise delivery of radiation and optimization of the dose intensity to specific volumes while sparing the dose...